Investigating the rise of robotic lung surgeries
The Rise in Robotic Atypical Segmentectomies: A Large Cancer Center Experience
This study looks at how often robotic surgeries for lung cancer are being done compared to traditional methods to see how they affect patient outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT04644952 on ClinicalTrials.gov |
What this trial studies
This study examines the increasing frequency of robotic atypical segmentectomies for lung carcinoma by retrospectively reviewing patient data from 2004 to 2019. The primary objectives include evaluating the annual rate of robotic segmentectomies and comparing them to traditional surgical methods such as open surgery and video-assisted thoracic surgery (VATS). By analyzing these trends, researchers aim to understand the impact of robotic surgery on lung resection outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who underwent lung resections between 2004 and 2019.
Not a fit: Patients who have not undergone lung resections or those treated outside the specified time frame may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the effectiveness and advantages of robotic surgery for lung cancer patients.
How similar studies have performed: Other studies have shown promising results with robotic surgical techniques, indicating potential benefits in surgical outcomes, making this approach relevant and timely.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who underwent a lung resection from 2004 to 2019
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: David C Rice — M.D. Anderson Cancer Center
- Study coordinator: David C. Rice
- Email: drice@mdanderson.org
- Phone: 713-563-9153
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.